<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04235192</url>
  </required_header>
  <id_info>
    <org_study_id>4222018004</org_study_id>
    <nct_id>NCT04235192</nct_id>
  </id_info>
  <brief_title>A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province</brief_title>
  <official_title>A Multicenter Case-control Study of Risk Factors for Premature Ejaculation in China's Shaanxi Province</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xijing Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>First Affiliated Hospital Xi'an Jiaotong University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Provincial People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Xi'an No.3 Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shaanxi Armed Police Corps Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Northwest Women's and Children's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xijing Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Through a multicenter case-control study on the risk factors of premature ejaculation in
      Shaanxi, to find out the related factors of the occurrence and development of premature
      ejaculation, to provide reference for personalized treatment, in order to improve the quality
      of sexual life of patients and partners.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 31, 2019</start_date>
  <completion_date type="Anticipated">October 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>IELT</measure>
    <time_frame>Within 6 months</time_frame>
    <description>Intra-vaginal Ejaculation Latency Time</description>
  </primary_outcome>
  <enrollment type="Anticipated">1340</enrollment>
  <condition>Premature Ejaculation</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with premature ejaculation in the outpatient department of the hospital were the
        case group, while patients without premature ejaculation in the outpatient department were
        the control group
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1) case group

               1. 18-64 years old, regular sexual life &gt; 6 months;

               2. Self-report of premature ejaculation;

               3. Able to complete questionnaires and scale scores independently. 2) control group

               1. 18-64 years old, regular sexual life &gt; 6 months;

               2. Both partners are satisfied with their sexual life;

               3. Able to complete questionnaires and scale scores independently.

        Exclusion Criteria:

          -  1) case group

               1. Those who are unable to have sex due to genital malformation;

               2. Patients with serious cardiovascular and cerebrovascular diseases;

               3. Severe mental disorders (history of epilepsy, mania, etc.);

               4. Have a history of brain trauma;

               5. People with a long history of substance abuse. 2) control group

               1. Patients with a history of mental illness;

               2. Oral selective serotonin (5-ht) reuptake inhibitors, tricyclic antidepressants,
                  triazolidine antidepressants, tramadol and sedatives
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>64 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jianlin Yuan, doctor</last_name>
    <phone>+86-136-0912-3155</phone>
    <email>jianliny@fmmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Xijing Hospital, Fourth Military Medical University</name>
      <address>
        <city>Xi'an</city>
        <state>Shaanxi</state>
        <zip>710032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fei Wu, master</last_name>
      <phone>+86-029-84771794</phone>
      <email>XJYYLLWYH@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 15, 2020</study_first_submitted>
  <study_first_submitted_qc>January 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 21, 2020</study_first_posted>
  <last_update_submitted>January 15, 2020</last_update_submitted>
  <last_update_submitted_qc>January 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>risk factor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Premature Ejaculation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

